BBG Advanced Therapies provides high-quality, well-characterized starting materials that support research, development, and manufacturing across the advanced therapies landscape. From recallable donors to RUO and cGMP-compliant leukapheresis collections, our starting materials are sourced, processed, and delivered with scientific rigor and operational precision. Collection procedures, documentation, and post-collection processing are all completed in accordance with 21 CFR 1271.
Whether you’are developing early-stage research programs or preparing for clinical-grade or commercial production, our team works with you to secure the right material, with the right specifications, at the right time.
Services and capabilities span donor recruitment, qualification, screening, and collection, all supported by BioBridge Global’s 50-year foundation in human cell and tissue innovation. Each step is designed to ensure consistency, compliance, and confidence at scale.
Expanding access to:
These starting materials are collected in U.S.-based facilities with experience in distributing products globally supported by integrated quality systems and full traceability from donor to delivery.
Access to reliable donors is critical to any successful cell therapy program. Our donor network includes:
available for longitudinal studies and comparability data.
to support research needs and therapeutic applications.
including screening, infectious disease testing, and eligibility documentation.
Donor management is supported by clinical research infrastructure and IRB oversight, ensuring the highest ethical and regulatory standards.*
*cGMP starting materials for further manufacturing and research are collected in accordance with 21 CFR 1271 at our collection facilities. All living donors are collected under IRB-approved protocols and research informed consent. Donor screening is compliant with FDA and international regulatory requirements as applicable.
Every therapeutic program requires something different. Our team partners with you to define material specifications and ensure that each unit meets your scientific and operational requirements.
Support includes:
This collaborative approach ensures that starting materials align with your project’s goals and regulatory expectations.
